Cost indicator,Deflation scenario 2,Deflation scenario 1,No inflation,Inflation scenario 1,Inflation scenario 2
Additional treatment costs,$334 ($267‒412),$314 ($250‒389),$296 ($235‒367),$280 ($222‒348),$266 ($210‒331)
Reduction in lifetime HIV costs (no discounting),"$789 ($597‒1,016)",$746 ($563‒963),$709 ($533‒916),$674 ($506‒873),$643 ($482‒834)
Benefits-to-cost ratio (no discounting),2.36 (1.87‒2.96),2.37 (1.88‒2.99),2.39 (1.89‒3.01),2.40 (1.90‒3.04),2.42 (1.91‒3.06)
Reduction in lifetime HIV costs (3.5% discounting),$510 ($386‒657),$483 ($364‒623),$458 ($344‒592),$436 ($327‒564),$416 ($311‒539)
Benefits-to-cost ratio (3.5% discounting),1.53 (1.21‒1.92),1.54 (1.22‒1.93),1.54 (1.22‒1.95),1.55 (1.23‒1.96),1.56 (1.23‒1.98)
Reduction in lifetime HIV costs (5% discounting),$435 ($329‒560),$411 ($310‒531),$390 ($293‒505),$372 ($279‒481),$355 ($265‒460)
Benefits-to-cost ratio (5% discounting),1.30 (1.03‒1.63),1.31 (1.04‒1.65),1.32 (1.04‒1.66),1.32 (1.05‒1.67),1.33 (1.05‒1.69)
